Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,961,307 papers from all fields of science
Search
Sign In
Create Free Account
Codependency Assessment Inventory
Known as:
CDAI
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Narrower (1)
FCAI
Broader (1)
Personality inventories
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab
K. Ebina
,
A. Miyama
,
+9 authors
H. Yoshikawa
Modern Rheumatology
2018
Corpus ID: 46953683
Abstract Objectives: To evaluate the effectiveness of add-on iguratimod (IGU) in patients with rheumatoid arthritis (RA) who…
Expand
2017
2017
The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab
S. Kaneshiro
,
K. Ebina
,
+9 authors
H. Yoshikawa
Modern Rheumatology
2017
Corpus ID: 19768430
Abstract Objectives: Tocilizumab (TCZ) shows good retention in patients with rheumatoid arthritis (RA), but no previous reports…
Expand
2016
2016
Magnetic resonance enterography or video capsule endoscopy – what do Crohn’s disease patients prefer?
A. Lahat
,
U. Kopylov
,
+10 authors
R. Eliakim
Patient Preference and Adherence
2016
Corpus ID: 17054131
Background Despite differences in the information obtained by capsule endoscopy (CE) and magnetic resonance enterography (MRE…
Expand
2012
2012
Determination of clinical outcome and pharmacoeconomics of anti–rheumatoid arthritis therapy using CDAI, EQ–5D–3L and EQ–VAS as indices of disease amelioration
P. Ghosh
,
A. Kandhare
,
V. S. Kumar
,
A. Rajmane
,
M. Adil
,
S. Bodhankar
2012
Corpus ID: 37845680
2009
2009
Resposta atenuada ao PPD no diagnóstico de infecção tuberculosa latente em pacientes com artrite reumatoide
C. Marques
,
Â. Duarte
,
+4 authors
E. F. D. Carvalho
2009
Corpus ID: 57260482
INTRODUCTION: With the introduction of Tumor Necrosis Factor Inhibitors (anti-TNFs) into rheumatological practice, it has become…
Expand
2005
2005
Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial.
E. Israeli
,
E. Goldin
,
+5 authors
Y. Ilan
World Journal of Gastroenterology
2005
Corpus ID: 37831163
AIM To evaluate safety and possible efficacy of induction of oral immune regulation using colitis extracted proteins (CEP) in…
Expand
2004
2004
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization
H. Herfarth
,
V. Gross
,
+8 authors
The Korean Gut Image Study Group
International Journal of Colorectal Disease
2004
Corpus ID: 23923819
Background and aimsThe nonsystemic steroid budesonide has been used to treat active ileocecal and ileocolonic Crohn's disease (CD…
Expand
2002
2002
Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease
C. Gelbmann
,
G. Rogler
,
+4 authors
J. Schölmerich
American Journal of Gastroenterology
2002
Corpus ID: 12571848
OBJECTIVES:Some patients with Crohn's disease (CD) do not respond to corticosteroid therapy. Furthermore, corticosteroids…
Expand
2002
2002
T-Cell Immune Parameters and Depression in Patients With Crohn's Disease
M. Rose
,
M. Hildebrandt
,
H. Fliege
,
S. Seibold
,
H. Mönnikes
,
B. Klapp
Journal of Clinical Gastroenterology
2002
Corpus ID: 34257934
Goals The causes of Crohn's disease (CD) are still considered to be unknown. It is likely that an immune defect leads to an…
Expand
1997
1997
No evidence of activated blood coagulation in Crohn's disease
G. Novacek
,
S. Kapiotis
,
G. Moser
,
W. Speiser
,
A. Gangl
,
H. Vogelsang
European Journal of Gastroenterology and…
1997
Corpus ID: 35611077
Background: Thromboembolism seems to be a significant and serious complication in Crohn's disease (CD), and multifocal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE